US Keytruda Market Growth and Future Outlook

added blog Health

2026-08-14 07:14:24 -

The United States oncology landscape is witnessing a significant transformation with the continued success of immunotherapy, particularly with the US Keytruda Market emerging as a dominant force in cancer treatment. Keytruda (pembrolizumab), a PD-1 inhibitor developed by Merck & Co., has revolutionized the management of various malignancies, offering new hope for patients with...

0 Comments 0 Shares 124 Views 0 Reviews